Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mitochondrial biogenesis, telomere length and cellular senescence in Parkinson’s disease and Lewy body dementia

20 Oct 2022

Abstract excerpt

Progressive age is the single major risk factor for neurodegenerative diseases. Cellular aging markers during Parkinson's disease (PD) have been implicated in previous studies, however the majority of studies have investigated the association of individual cellular aging hallmarks with PD but not jointly. Here, we have studied the association of PD with three aging hallmarks (telomere attrition, mitochondrial...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetics, Aging, and Longevity in Model Organisms
Share to Mitochondrial Function and Pathology
Share to Telomeres, Telomerase, and Senescence

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36266468
DOI: 10.1038/s41598-022-22400-z

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mitochondrial biogenesis, telomere length and cellular senescence in Parkinson’s disease and Lewy body dementiaPMID 36266468Read ↗

Aging, cellular senescence and Parkinson's diseaseSemantic proximity Read ↗

Longitudinal Changes in Mitochondrial DNA Copy Number and Telomere Length in Patients with Parkinson’s DiseaseSemantic proximity Read ↗

Brain Mitochondria, Aging, and Parkinson’s DiseaseSemantic proximity Read ↗

Lewy body pathology is associated with mitochondrial DNA damage in Parkinson's diseaseSemantic proximity Read ↗

Telomere Attrition in Neurodegenerative DisordersSemantic proximity Read ↗

Increase of deleted mitochondrial DNA in the striatum in Parkinson's disease and senescence.Semantic proximity Read ↗

Reduced mitochondrial DNA copy number is a biomarker of Parkinson's diseaseSemantic proximity Read ↗

Telomere length and risk of Parkinson's diseaseSemantic proximity Read ↗

Reduced Telomere Length in Neurodegenerative Disorders May Suggest Shared BiologySemantic proximity Read ↗

Unraveling Parkinson’s Disease Neurodegeneration: Does Aging Hold the Clues?Semantic proximity Read ↗

Evidence for polymerase gamma, POLG1 variation in reduced mitochondrial DNA copy number in Parkinson's disease.Semantic proximity Read ↗

Circulating cell-free mitochondrial DNA levels in Parkinson’s disease are influenced by treatmentSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.